Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
COVID-19 vaccine market set to reach $19.5 bn by 2026: GlobalData
COVID-19 vaccines based on mRNA technology dominate the 7MM in 2021 with a market share of 95.4 per cent and $9.5 billion in sales…
2021 is a key year for personalised neoantigen immuno-oncology therapeutics: GlobalData
The four molecules expected to launch first, autogene cevumeran, GRANITE-001, ATL001, and Genocea Biosciences’ GEN-009 have…
US claims it is unable to send COVID vaccines as India needs to review its legal provisions
We are ready to ship those vaccines expeditiously when we have a green light from the Government of India, said State Department…
Govt exempts customs duty on imports of raw materials for COVID test kits, APIs for Amphotericin B
Exemption on raw materials for manufacturing COVID test kits would be till September 30, 2021, while specified APIs/ excipients…
Equipping Progress
The lab equipment market is expected to boom as investments in life sciences R&D increase to deal with existing and emerging…
SII to commence manufacturing of Sputnik COVID-19 vaccine in September
As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year
Lupin launches Tavaborole Topical Solution in US
It is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or…
Serum Institute to start manufacturing Sputnik vaccine in September
The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said
US FDA adds new warning on J&J COVID-19 vaccine for Guillain-Barre´ syndrome
It said J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations,…
Shortage of Sputnik V’s second dose to delay India’s full roll out, says Dr…
Dr Reddy's had received about three million first doses by 1st June and about 360,000 doses of the second by early this month, the…